Pharmaceutics International Inc. (Pii) is offering a $100,000 grant for an early-stage drug therapy.   An emerging drug therapy that meets Pii’s requirements could be eligible for a $100,000 credit applied to work performed by Pii at its Hunt Valley, MD campus. That means Pii will deduct $100,000 from the cost of their work.   According to a survey of biotech companies by Biocentury and investment management firm Sanford C. Bernstein, most emerging biopharma companies do not have the required fu...